Divis Laboratories Quarterly Results for Trading Insights
DIVISLAB • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹689 Cr
QSept 2025
Divis Laboratories Quarterly Results Key Highlights
- Revenue of ₹2,860 Cr in Sept 2025 (+7.1% vs Mar 2025, +17.0% vs Sept 2024)
- Net Profit of ₹689 Cr in Sept 2025 (+4.1% vs Mar 2025, +35.1% vs Sept 2024)
- EBITDA of ₹1,033 Cr in Sept 2025 (+6.3% vs Mar 2025)
- Operating Margin of 33.0% in Sept 2025 (-1.0pp vs Mar 2025)
- Earnings Per Share of ₹25.97 in Sept 2025 (+4.2% vs Mar 2025)
Divis Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 2,860 | 2,671 | 2,529 | 2,692 | 2,444 | 7.1% | 17.0% |
| Net Profit (₹ Cr) | 689 | 662 | 545 | 583 | 510 | - | - |
| EBITDA (₹ Cr) | 1,033 | 972 | 848 | 904 | 822 | - | - |
| EPS (₹) | 25.97 | 24.93 | 20.49 | 21.98 | 19.20 | - | - |
| Operating Margin (%) | 33.0% | 34.0% | 30.0% | 31.0% | 31.0% | - | - |
Divis Laboratories Share Price Trend Around Quarterly Results
Visualize Divis Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Divis Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Divis Laboratories
Additional stock information and data for DIVISLAB
Revenue Trend (₹ Cr)
Dec 2025
2,692
Jun 2025
2,529
Mar 2025
2,671
Sept 2025
2,860
Net Profit Trend (₹ Cr)
Dec 2025
583
Jun 2025
545
Mar 2025
662
Sept 2025
689
Operating Margin Trend (%)
Dec 2025
31.0%
Jun 2025
30.0%
Mar 2025
34.0%
Sept 2025
33.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Divis Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹438,094.57 Cr | 1801.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 138.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4390.0 | 3,219 | 591 | +11.3% | - | 18.4% | 250.3 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,630.25 Cr | 1292.3 | 9,135 | 1,337 | +1.1% | - | 14.6% | 79.9 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1314.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 78.6 |
|
Lupin
Sept 2025 |
₹105,205.33 Cr | 2314.9 | 6,921 | 1,485 | +23.2% | - | 21.5% | 71.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores